Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms Wuqing Huang, Jan Sundquist, Kristina Sundquist, Jianguang Ji Gastroenterology Volume 157, Issue 3, Pages 672-681.e4 (September 2019) DOI: 10.1053/j.gastro.2019.05.012 Copyright © 2019 AGA Institute Terms and Conditions
Supplementary Figure 1 A flowchart for the study population. Gastroenterology 2019 157, 672-681.e4DOI: (10.1053/j.gastro.2019.05.012) Copyright © 2019 AGA Institute Terms and Conditions
Supplementary Figure 2 Value of the joint minimal strength of association that an unmeasured confounder must associate with PDE5 inhibitor use and risk of CRC to fully explain the observed HR in our study. Gastroenterology 2019 157, 672-681.e4DOI: (10.1053/j.gastro.2019.05.012) Copyright © 2019 AGA Institute Terms and Conditions